Young Investigator Awardee announced

Article

Juan F. Tabernero, PhD, was announced as the winner of the 2012 Carl Zeiss European Young Investigator Award during the EVER Congress in Nice, France.

Juan F. Tabernero, PhD, was announced as the winner of the 2012 Carl Zeiss European Young Investigator Award during the EVER Congress in Nice, France.

The annual award recognized Dr Tabernero's scientific contribution to ophthalmic research, including visual psychophysics, physiological and biomedical optics and overcoming the optical limitations of vision.

Currently, Dr Tabernero is working on the research of new trends in cataract, presbyopia and myopia. He commented, "We are working on understanding the mechanical properties of the crystalline lens and intraocular lenses for cataracts, especially on the stability after surgery. We are also evaluating some non-conventional approaches to the problem of presbyopia (i.e., the pinhole effect applied to corneal inlays). Concerning myopia research, I am really looking forward to the outcome of the clinical studies using new optical solutions to stop the progression of myopia. We will have to evaluate those results and check/recheck the validity of the peripheral hyperopia hypothesis as an anti-myopic optical solution.”

Dr Raymund Heinen, CEO of Carl Zeiss Vision, stated, "We congratulate sincerely Juan Tabernero on winning our young researcher’s award. His outstanding work gives proof that, in the field of ophthalmic research and better vision, also in the future, breakthrough innovations can be expected."

More information about the award can be found here.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.